ofa semaglutide lawsuit FDA sued over 'reckless and arbitrary' decision Ozempic Vision Lawsuit | Attorneys

After three months on the medication, tirzepatide users lost an average of 5.9% of their body weight, whereas semaglutide users lost an average of 3.6% of their body weight

These adverse effects are thought to be rare but should be considered by people who wish to use GLP-1 medications for weight loss

Persistent or unexplained stool colour changes warrant prompt GP evaluation to exclude serious pathology

You most likely know it as Ozempic or Wegovy , which both share it as the active ingredient

Ozempic is also used to lower the risk of major cardiovascular events in people with diabetes and heart disease and reduce the chance of worsening kidney problems in people with diabetes and chronic kidney disease